<DOC>
	<DOCNO>NCT00357773</DOCNO>
	<brief_summary>To demonstrate efficacy T1225 1.5 % eye drop , comparison reference product , treatment purulent bacterial conjunctivitis , ass safety</brief_summary>
	<brief_title>Efficacy Safety T1225 1.5 % Versus Tobramycin 0.3 % Treatment Purulent Bacterial Conjunctivitis</brief_title>
	<detailed_description>The aim present study compare efficacy safety T1225 1.5 % eye drop administer BID 3 day comparison reference antibiotic eye drop , tobramycin , treatment purulent bacterial conjunctivitis . The study conduct Phase III , multicentre , international , investigator-masked , randomised , parallel-group , non-inferiority study newborn , child , adult .</detailed_description>
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Bacterial</mesh_term>
	<mesh_term>Tobramycin</mesh_term>
	<criteria>Male female &gt; = 1 day old ( newborn , infant , child , adult ) ; write informed consent patient legally acceptable representative ; purulent bacterial conjunctivitis ( unilateral bilateral ) define bulbar conjunctival injection ( mild , moderate , severe ) AND conjunctival purulent discharge ( mild , moderate severe ) . Bacterial conjunctivitis diagnose &gt; = 7 day ago ; bacterial infection due trauma foreign body ; dacryocystitis ; corneal ulceration keratitis ; viral ocular infection ; close angle glaucoma ; acute allergy conjunctivitis ; clinically significant ocular abnormality ; organic amblyopia , monophthalmia ; correct visual acuity 20/100 ; contact lens wearer ; newborn ( i.e . 02 month old ) bear term ( &lt; 37 week amenorrhea ) ; ocular surgery , laser situ keratomileusis ( LASIK ) , laser epithelial keratomileusis ( LASEK ) , photorefractive keratectomy ( PRK ) last 12 month ; ocular laser treatment last 3 month ; systemic macrolide antibiotic last month ; systemic steroid last 2 week study ; topical ocular macrolide antibiotic and/or topical ocular steroid and/or nonsteroidal antiinflammatory drug ( NSAIDs ) last week ; topical ( ocular , nasal , bronchial etc . ) treatment and/or systemic NSAIDs last day ; immunosuppressives and/or systemic antibiotic D0 .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2006</verification_date>
</DOC>